Drug discovery

Mouse in laboratory
#Bispecific therapeutics #Drug discovery #Human disease models #Mouse models #Preclinical development #Preclinical investigations #Toxicology

Case Study: Streamline preclinical drug discovery

A new Case Study is now available to download for free: ‘In Vivo Evaluation Of Bispecific-Cell Engager Efficacy & Safety‘. Discover a clinically predictive and reproducible platform developed by The Jackson Laboratory for simultaneous efficacy and safety assessment. This platform identifies patient-therapy combinations at risk of developing… Read More

#News

#Bispecific therapeutics #Drug discovery #Human disease models #Mouse models #Preclinical development #Preclinical investigations #Toxicology

Streamline preclinical drug discovery: PBMC-humanised mouse models

Discover a clinically predictive and reproducible platform developed by The Jackson Laboratory for simultaneous efficacy and safety assessment. This platform identifies patient-therapy combinations at risk of developing severe inflammatory syndrome, a potentially fatal complication. Optimise the safety profiles of your immunomodulatory therapeutics before first-in-human trials by leveraging this platform. In… Read More

#Resources

#Cancer research #Drug discovery #eBook #Oncology

Breakthroughs in oncology research and drug discovery

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More

#DDW eBooks #Intelligence

CRISPR-Cas9
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening at scale: A cost-effective approach

Join DDW for this free event, ‘CRISPR screening at scale: Achieving 1M cell data sets with an instrument-free, cost-effective approach‘, which is supported by Scale Biosciences. The event will take place on 25 April 5 PM BST / 6PM CEST / 9AM PST. Read More

Webinar date:
Brought to you by ScaleBio
#News

CRISPR-Cas9
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening at scale: Achieving 1m cell data sets with an instrument-free, cost-effective approach

Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel. Genome-wide screens are becoming the standard for drug discovery to power unbiased identification of drug targets across gene regulatory networks. Requiring single-cell… Read More

Webinar date:
Brought to you by ScaleBio
#Webinars

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Last chance to register: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Cancer research #Drug discovery #In Focus Report #Oncology

Oncology Research: Where are the breakthroughs & innovation?

Download this exclusive DDW eReport to learn more about: Oncology drug discovery and development: A market overview The technologies and therapeutic approaches that will drive the future of cancer drug discovery Oncology, drug discovery and the potential of organoids The research driving advancements in oncology and recent approvals in the sector… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Cancer research #Drug discovery

DDW eBook: Breakthroughs in oncology research and drug discovery

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More

#DDW eBooks

#Collaboration #Drug development #Drug discovery #Partnership

Six March 2024 deals advancing drug discovery

Allogene Therapeutics and Arbor Biotechnologies Biotechnology companies Allogene Therapeutics and Arbor Biotechnologies entered a non-exclusive, global gene editing licensing agreement for use of Arbor’s proprietary CRISPR gene-editing technology in Allogene’s AlloCAR T platform for the treatment of autoimmune disease (AID). “The potential for CAR T as… Read More

#News

#Antibodies #Cancer #Cancer research #Diagnostics #Drug discovery #Fibroblasts #Flow Cytometry #Immunology #Oncology #Tumour biology

Podcast: Flow cytometry for drug discovery research

This is the latest episode of the free DDW narrated podcast, titled “Flow cytometry for drug discovery research” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Flow cytometry technologies and cancer associated fibroblasts and Leveraging… Read More

#News

Research laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Guide

DDW Cell & Gene Therapy Guide 2024

Download the exclusive Guide and read about: Where is the global innovation in CGT and what opportunities is it creating? What does the CGT sector need to overcome challenges and get to market faster? Does the CGT sector have the skills required to ensure future success and of not, how… Read More

#DDW eBooks #DDW Guides

#Drug discovery

Case Study: Streamline Preclinical Drug Discovery: PBMC-Humanised Mouse Models

Discover a clinically predictive and reproducible platform developed by The Jackson Laboratory for simultaneous efficacy and safety assessment. This platform identifies patient-therapy combinations at risk of developing severe inflammatory syndrome, a potentially fatal complication. Optimise the safety profiles of your immunomodulatory therapeutics before first-in-human trials by leveraging this platform. In… Read More

#Case Studies

Team of scientists working in a lab
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: Biotech experts share their tips for effective collaboration

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Artificial intelligence (AI) #Collaboration #Drug discovery #Elsevier #Iktos #Partnership

Elsevier and Iktos launch AI-powered drug discovery database

Elsevier and Iktos have partnered to strengthen Elsevier’s chemistry solution, Reaxys, by combining the company’s chemistry data with synthetic planning AI technologies developed by Iktos. The partnership aims to support R&D organisations to decrease the time required to complete Design-Make-Test-Analyse cycles of small molecules, thus reducing… Read More

#Business & Investment #News

#Drug development #Drug discovery #International Women's Day

IWD 2024: Eight women taking the lead in drug discovery

For International Women’s Day (IWD), Diana Spencer highlights DDW interviews with eight inspirational women leaders in drug discovery and development. Stefanie Dedeurwaerdere, UCB Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role,… Read More

#Exclusive Content